Sign in

CIK 0001020214

  • Accelerated filer
Ticker
CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680262011
Phone
+1 925-288-6000
Business address
1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
  1. 4 Open-market sale Chief Medical Officer sold 165,000 shares at an average $7.68 ($1,267,750)
  2. 4 Exercise or conversion Director acquired 4,296 shares (option exercise)
  3. 4 Grant or award Director acquired 24,784 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Exercise or conversion President and CEO acquired 100,000 shares (option exercise)
  6. 4 Open-market sale Director sold 12,877 shares at $6.25 ($80,481)
  7. 4 Grant or award Director acquired 17,525 shares (grant or award)
  8. 4 Grant or award Director acquired 14,888 shares (grant or award)
  9. 4 Grant or award Director acquired 14,888 shares (grant or award)
  10. 4 Grant or award Director acquired 14,888 shares (grant or award)
  11. 4 Grant or award Director acquired 14,888 shares (grant or award)
  12. 4 Grant or award Director acquired 14,888 shares (grant or award)
  13. 4 Exercise or conversion Director acquired 13,228 shares (option exercise)
  14. 4 Open-market sale Director sold 5,000 shares at $5.75 ($28,735)
  15. 4 Exercise or conversion Chief Scientific Officer acquired 25,200 shares (option exercise)
  16. 4 Shares withheld for taxes President and CEO gave up 233,859 shares (to pay taxes)
  17. 4 Open-market sale Chief Operating Officer sold 37,149 shares at $6.38 ($236,925)
  18. 4 Open-market sale Chief Financial Officer sold 29,331 shares at $6.38 ($187,064)
  19. 4 Open-market sale President and CEO sold 156,407 shares at $6.38 ($997,517)
  20. 4 Open-market sale Chief Scientific Officer sold 23,775 shares at $6.38 ($151,630)

Page 9 of 36 · 701 filings